Analysis of Recent Papers in Hypertension Nighttime Administration of At Least One Antihypertensive Medication is Associated With Better Blood Pressure Control and Cardiovascular Outcomes in Patients With Type 2 Diabetes or Chronic Kidney Disease

被引：6
|
作者：
Basile, Jan N. [2 ]
Bloch, Michael J. [1 ]
机构：
[1] Univ Nevada, Sch Med, Dept Internal Med, Reno, NV 89557 USA
[2] Med Univ S Carolina, Ralph H Johnson VA Med Ctr, Div Gen Internal Med Geriatr, Seinsheimer Cardiovasc Hlth Program, Charleston, SC 29425 USA
来源：
JOURNAL OF CLINICAL HYPERTENSION | 2013年 / 15卷 / 01期
关键词：
RISK;
D O I：
10.1111/jch.12028
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：2 / 4
页数：3
相关论文
共 50 条
  • [1] Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes
    Viazzi, Francesca
    Greco, Eulalia
    Ceriello, Antonio
    Fioretto, Paola
    Giorda, Carlo
    Guida, Pietro
    Russo, Giuseppina
    De Cosmo, Salvatore
    Pontremoli, Roberto
    KIDNEY & BLOOD PRESSURE RESEARCH, 2018, 43 (02): : 422 - 438
  • [2] Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication
    Mancia, Giuseppe
    Cannon, Christopher P.
    Tikkanen, Ilkka
    Zeller, Cordula
    Ley, Ludwin
    Woerle, Hans J.
    Broedl, Uli C.
    Johansen, Odd Erik
    HYPERTENSION, 2016, 68 (06) : 1355 - 1364
  • [3] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Rossing, Peter
    Ruilope, Luis M.
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    CIRCULATION, 2020, 142 (24) : E470 - E470
  • [4] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    CIRCULATION, 2021, 143 (06) : 540 - 552
  • [5] Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
    Agarwal, Rajiv
    Filippatos, Gerasimos
    Pitt, Bertram
    Anker, Stefan D.
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Nowack, Christina
    Gebel, Martin
    Ruilope, Luis M.
    Bakris, George L.
    EUROPEAN HEART JOURNAL, 2022, 43 (06) : 474 - +
  • [6] Blood pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
    Ruilope, Luis M.
    Agarwal, Rajiv
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Sarafidis, Pantelis
    Schmieder, Roland E.
    Joseph, Amer
    Rethemeier, Nicole
    Nowack, Christina
    Bakris, George L.
    HYPERTENSION, 2022, 79 (12) : 2685 - 2695
  • [7] Blood pressure control and its associated factors in patients with hypertension and type 2 diabetes
    Jarab, Anan S.
    Al-Qerem, Walid
    Alqudah, Salam
    Heshmeh, Shrouq R. Abu
    Mukattash, Tareq L.
    Alzoubi, Karem H.
    ELECTRONIC JOURNAL OF GENERAL MEDICINE, 2023, 20 (03):
  • [8] Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes
    De Cosmo, Salvatore
    Viazzi, Francesca
    Piscitelli, Pamela
    Giorda, Carlo
    Ceriello, Antonio
    Genovese, Stefano
    Russo, Giuseppina
    Guida, Pietro
    Fioretto, Paola
    Pontremoli, Roberto
    JOURNAL OF HYPERTENSION, 2016, 34 (10) : 2090 - 2098
  • [9] Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
    Wanner, Christoph
    Lachin, John M.
    Inzucchi, Silvio E.
    Fitchett, David
    Mattheus, Michaela
    George, Jyothis
    Woerle, Hans J.
    Broedl, Uli C.
    von Eynatten, Maximilian
    Zinman, Bernard
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    Lienart, F.
    Mortelmans, J.
    CIRCULATION, 2018, 137 (02) : 119 - 129
  • [10] Summary of Research: Cardiovascular and Kidney Outcomes with Finerenone in Patients with Type 2 Diabetes and Chronic Kidney Disease-The FIDELITY Pooled Analysis
    Humle, Karin
    Klanger, Boris
    Kolkhof, Peter
    Rosas, Sylvia E.
    Rossing, Peter
    Wright, Eugene
    Jefferson, Nichole
    DIABETES THERAPY, 2024, 15 (09) : 1861 - 1864
12345